Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis MyNeuroNews, 14 Dec 2020 Purpose: To assess the efficacy and safety of rituximab treatment as second-line immunotherapy in pediatric cases of anti-NMDA…